Vanguard Global Advisers’s IGC Pharma IGC Stock Holding History
Bought
Maintained
Sold
Other funds holding IGC
Vanguard Global Advisers's IGC Position: Q3 2026 in Review
Vanguard Global Advisers held its IGC Pharma (IGC) position steady in Q3 2026 at 14,944 shares worth $4.02K. The position accounts for ﹤0.01% of the portfolio, ranked #3612.
Vanguard Global Advisers first reported a position in IGC in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.06K in Q2 2026. 29 funds tracked by Wall St. Rank hold IGC as of Q3 2026.
- Vanguard Global Advisers held 14,944 shares of IGC Pharma worth $4.02K as of Q3 2026.
- Vanguard Global Advisers left its IGC Pharma share count unchanged in Q3 2026.
- IGC Pharma made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3612 holding.
- Vanguard Global Advisers first reported a position in IGC Pharma in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's IGC Pharma position peaked at $4.06K in Q2 2026.
- 29 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.